NCT02527369

Effect of the XP1100RF Therapy on Thighs Circumference Reduction

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: BTL Industries Ltd. · Industry
• Sex: All
• Age: 22 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This study was designed to demonstrate safety and efficacy of the XP1100RF for non-invasive temporary reduction of thighs circumference by disruption of adipocyte cells.

Detailed description

This study is a prospective, single-arm, open label study of thighs circumference reduction following 4 treatment sessions delivered once a week over a 4-week period. The objective of the study is to demonstrate the effectiveness of the treatment after 30-day in achieving thighs circumference reduction of ≥1 cm relative to the base line assessment.

Conditions

• Thighs Circumferential Reduction
• Subcutaneous Fat Cell Disruption

Interventions

Type	Name	Description
DEVICE	XP1100RF	Treatment of adipose tissue within the fat layer with XP1100RF device.

Timeline

• Start date: 2014-07-01
• Primary completion: 2015-03-01
• Completion: 2015-03-01
• First posted: 2015-08-19
• Last updated: 2020-07-13